๐ข Recruiting
Phase 1
๐ Investigational Drug / Biologic
NCT06515613
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
๐ University of Arkansas Winthrop P. Rockefeller Cancer Institute โ Little Rock, Arkansas
View Study & Checklist โ